X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
cancer (8) 8
index medicus (6) 6
surgery (6) 6
aged (5) 5
carcinoma (5) 5
chemotherapy (5) 5
gastroenterology & hepatology (5) 5
middle aged (5) 5
neoadjuvant therapy (5) 5
therapy (5) 5
tumor proteins (5) 5
apoptosis (4) 4
cardiac & cardiovascular systems (4) 4
female (4) 4
adult (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
biopsy (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - pathology (3) 3
care and treatment (3) 3
cisplatin - administration & dosage (3) 3
combined modality therapy (3) 3
esophageal cancer (3) 3
expression (3) 3
genes, p53 - genetics (3) 3
genetic aspects (3) 3
genotype (3) 3
liver cancer (3) 3
lung neoplasms - genetics (3) 3
medicine & public health (3) 3
metastasis (3) 3
mutations (3) 3
polymerase chain reaction (3) 3
predictive value of tests (3) 3
respiratory system (3) 3
abridged index medicus (2) 2
adenocarcinoma - genetics (2) 2
adenocarcinoma - pathology (2) 2
animals (2) 2
antineoplastic agents - therapeutic use (2) 2
biomarkers, tumor - genetics (2) 2
breast neoplasms - drug therapy (2) 2
carcinoma, hepatocellular - genetics (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
cardiology and cardiovascular medicine (2) 2
cardiothoracic surgery (2) 2
cell line, tumor (2) 2
chemoradiotherapy (2) 2
core needle biopsy (2) 2
dna methylation (2) 2
dna mutational analysis (2) 2
esophageal neoplasms - pathology (2) 2
esophageal neoplasms - therapy (2) 2
esophagus (2) 2
fibroblasts (2) 2
fish (2) 2
growth factors (2) 2
hepatocarcinogenesis (2) 2
her-2/neu (2) 2
her2/neu (2) 2
immunohistochemistry (2) 2
in situ hybridization, fluorescence (2) 2
liver neoplasms - genetics (2) 2
lung cancer, non-small cell (2) 2
male (2) 2
medical colleges (2) 2
minimally invasive esophagectomy (2) 2
mutation (2) 2
neoadjuvant chemoradiation (2) 2
neoplasm staging (2) 2
oncology (2) 2
oncology, experimental (2) 2
p53 (2) 2
phenotype (2) 2
positron-emission-tomography (2) 2
predictive marker (2) 2
prognosis (2) 2
pulmonary and respiratory medicine (2) 2
receptor (2) 2
research (2) 2
robots (2) 2
rodents (2) 2
survival (2) 2
survival analysis (2) 2
trastuzumab (2) 2
treatment outcome (2) 2
up-regulation (2) 2
5-fu (1) 1
5-methylcytosine (1) 1
5‐fu (1) 1
abdominal surgery (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - therapy (1) 1
adenovirus vector (1) 1
adenoviruses (1) 1
aeg (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2014, Volume 148, Issue 5, pp. 2280 - 2286
Background Fluorouracil and cisplatin have been used most frequently as neoadjuvant therapy for esophageal cancer. Both drugs are believed to act via a... 
Cardiothoracic Surgery | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | GENOTYPE | GUIDELINES | VALIDATION | CHEMORADIOTHERAPY | PATTERNS | IMMUNOHISTOCHEMICAL RESULT | CHEMOTHERAPY | PREDICTIVE MARKER | RESPIRATORY SYSTEM | MUTATION | CARCINOMA | Predictive Value of Tests | Adenocarcinoma - pathology | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Austria | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Esophageal Neoplasms - mortality | Female | Neoadjuvant Therapy | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Genetic Predisposition to Disease | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Esophagectomy | Treatment Outcome | Adenocarcinoma - drug therapy | Phenotype | Carcinoma, Squamous Cell - drug therapy | Esophageal Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Biomarkers, Tumor - genetics | Mutation | Esophageal Neoplasms - drug therapy | Adenocarcinoma - mortality | Care and treatment | Cancer patients | Patient outcomes | Gastrointestinal diseases | Oncology, Experimental | Research | Tumor proteins | Esophageal cancer | Cancer | Fluorouracil
Journal Article
The Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 2008, Volume 135, Issue 5, pp. 1036 - 1041
Journal Article
Journal Article
Journal Article
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 09/2011, Volume 1232, Issue 1, pp. 265 - 291
The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of... 
esophageal cancer | integrated PET/CT scan | EGFR | FDG PET scan | p53 | adenovirus vector | two‐stade esophagectomy | sentinel node | Barrett's esophagus | robot assisted thoracolaparoscopic esophagectomy | high risk patients | 5‐FU | cisplatin | FOLFOX | AEG | sentinel lymph nodes | gamma probe | residual disease | R0 resection | chemoradiotherapy | adenocarcinoma | gefitinib | prognosis | lymphadenectomy | robotic surgery | neoadjuvant chemotherapy | radiotherapy | Siewert 's classification | multimodality therapy | PET tracer | HER2 | minimally invasive esophagectomy | chemoradiation | molecular markers | submucosal invasion | Adenocarcinoma | Neoadjuvant chemotherapy | Prognosis | Sentinel lymph nodes | Minimally invasive esophagectomy | Residual disease | Chemoradiotherapy | Two-stade esophagectomy | Lymphadenectomy | Molecular markers | Chemoradiation | Sentinel node | Gefitinib | Submucosal invasion | Gamma probe | Radiotherapy | Robot assisted thoracolaparoscopic esophagectomy | Cisplatin | P53 | Robotic surgery | Adenovirus vector | Multimodality therapy | High risk patients | Integrated PET/CT scan | Esophageal cancer | 5-FU | GASTROESOPHAGEAL JUNCTION | SURGICAL THERAPY | PATHOLOGICAL RESPONSE | NEOADJUVANT CHEMORADIATION | GASTROINTESTINAL CANCER | two-stade esophagectomy | ESOPHAGOGASTRIC JUNCTION | HISTOPATHOLOGIC RESPONSE | SENTINEL LYMPH-NODE | MULTIDISCIPLINARY SCIENCES | POSITRON-EMISSION-TOMOGRAPHY | TARGETED AGENTS | GASTROENTEROLOGY & HEPATOLOGY | Adenocarcinoma - pathology | Barrett Esophagus - pathology | Adenocarcinoma - therapy | Humans | Survival Analysis | Combined Modality Therapy | Sentinel Lymph Node Biopsy | Esophageal Neoplasms - therapy | Esophageal Neoplasms - pathology | Chemotherapy | Dysplasia | PET imaging | Tracers (Biology) | Adenoviruses | Monoclonal antibodies | Drug therapy | Tumor proteins | Robots | Cancer | Biopsy | Mortality | Therapy | Indication | Assessments | Frozen | Patients | Esophagus
Journal Article
Journal Article
Translational Oncology, ISSN 1936-5233, 2013, Volume 6, Issue 6, pp. 715 - IN27
Change of DNA cytosine methylation (5mC) is an early event in the development of cancer, and the recent discovery of a 5-hydroxymethylated form (5hmC) of... 
Oncology | MODIFIER | METASTASIS | MELANOMA | DNA METHYLATION | 5-METHYLCYTOSINE | CHROMATIN | ONCOLOGY | FEZ1/LZTS1 | DOWN-REGULATION | MUTATIONS | CARCINOMA
Journal Article
Journal Article